Literatura

Przyczyny niepłodności

Endometrioza

• Morcos RN, Gibbons WE:  Effect of Peritoneal Fluid on In Vitro Cleavage of 2-Cell Mouse Embryos: Possible Role in Infertility Associated with Endometriosis.  Fertil Steril 44:678,1985.
• Garrido N, Pellicer A, Remohi J, et al:  Uterine and Ovarian Function in Endometriosis.  Sem Reprod Med 21:183-191, 2003.
• Giudice LC, Tazuke SL, Swiersz L:  Status of Current Research on Endometriosis. J Reprod. Med 43:252-262, 1998.
• Kim AH, Adamson GD:  Does Therapy for Minimal/Mild Endometriosis Enhance Conception?  Inf Reprod Med Clin North Am 8:623-637, 1997.
• Possible Role in Infertility Associated with Endometriosis.  Edman CD:  The Effects of Steroids on the Endometrium.  In:  Speroff L. (Ed) Seminars in Reproductive Endocrinology.  1:179-187, 1983.
• Ronnberg L, Kauppila A, Rajaniemi H:  Luteinizing Hormone Receptor Disorder in Endometriosis. 42:64-68, 1984.
• Hirama Y, Ochiai K:  Estrogen and Progesterone Receptors of the Out-of-Phase Endometrium in Female Infertile Patients.  Fertil Steril 63:984-988, 1995.
• Knapp VJ:  How Old is Endometriosis? Late 17th – and 18th – Century European Descriptions of the Disease.  Fertil Steril 72:10-14, 1999.
• Hastings JM, Fazleabas AT: Future Directions in Endometriosis Research.  Sem Reprod Med 21:255-262, 2003.
• Endometriosis Association: Characteristics of Women with Endometriosis.  Educational Handout.  Milwaukee, WI.
• Chapron C, Dubuisson J-B, Pansini V, et al:  Routine Clinical Examination is not Sufficient for Diagnosing and Locating Deep Infiltrating Endometriosis.  J Am Assoc Gynecol Laparosc 9:115-119, 2002.
• Eskenazi B, Warner M, Bonsignore L, et al:  Validation Study of Nonsurgical Diagnosis of Endometriosis.  Fertil Steril 76:929-935, 2001.
• Mettler L, Schollmeyer T, Lehmann-Willenbrock E, et al:  Accuracy of Laparoscopic Diagnosis of Endometriosis.  JSLS. 7:15-18, 2003.
• Buchweitz O, Poel T, Diedrich K, et al:  The Diagnostic Dilemma of Minimal and Mild Endometriosis Under Routine Conditions.  J Am Assoc Gynecol Laparosc 10:85-89, 2003.
• Schweppe K-W, Ring D:  Peritoneal Defects and the Development of Endometriosis in Relation to the Timing of Endoscopic Surgery During the Menstrual Cycle.  Fertil Steril 78:763-766, 2002.
• Demco L: Novel Approaches to Diagnosing and Treating Endometriosis.  Contemporary  OB/GYN 12-18, April 15, 2004.
• Redwine DB:  Ovarian Endometriosis:  A Marker for More Extensive Pelvic and Intestional Disease.  Fertil Steril 72:310-315, 1999.
• Roberts LM, Redan J, Reich H:  Extraperitoneal Endometriosis with Catamenial Pneumothoraces:  A Review of the Literature.  JSLS. 7:371-375, 2003.
• Matalliotakis IM, Goumenou AG, Koumantakis GE, et al:  Pulmonary Endometriosis in a Patient with Unicornuate Uterus and Noncommunicating Horn.  Fertil Steril 78:183-185, 2002.
• Mendes LE, Echt L, Rock JA, et al:  Pulmonary Endometriosis:  A Clinical Review.  J Pelv Surg 3:130-135, 2000.
• Seltzer VL, Benjamin F:  Treatment of Pulmonary Endometriosis with a Long-Acting GnRH Agonist.  Obstet Gynecol 76:929-931, 1990.
• Nackley AC, Yeko TR:  Ureteral Displacement Associated with Pelvic Peritoneal Defects and Endometriosis.  J M Assoc Gynecol Laparosc 7:131-133, 2000.
• Zanetta G, Webb MJ, Segura JW:  Ureteral Endometriosis Diagnosed at Ureteroscopy.  Obstet Gynecol 91:857-859, 1998.
• DavisOK, Schiff I:  Endometriosis with Unilateral Ureteral Obstruction and Hypertension:  A Case Report.  J Reprod Med 33:470-472, 1988.
• Henkel A, Christensen B, Schindler AE:  Endometriosis:  A Clinically Malignant Disease.  Eur J Obstet Gynecol 82:209-211, 1999.
• Redwine DB:  Diaphragmatic Endometriosis:  Diagnosis, Surgical Management, and Long-Term Results of Treatment.  Fertil Steril 77:288-296, 2002.
• Nezhat C, Seidman DS, Nezhat F, et al: Laparoscopic Surgical Management of Diaphragmatic Endometriosis. Fertil Steril 69:1048-1055, 1998.
• Fedele L, Bianchi S, Raffaelli R, et al:  Phantom Endometriosis of the Sciatic Nerve.  Fertil Steril 72:727-729, 1999.
• Torkelson SJ, Lee RA, Hildahl DB:  Endometriosis of the Sciatic Nerve:  A Report of Two Cases and a Review of the Literature.  Obstet Gynecol 71:473-477, 1988.
• Pollack R, Gordon PH, Ferenczy A, et al:  Perineal Endometriosis:  A Case Report.  J Reprod Med 35:109-112, 1990.
• Dougherty LS, Hall T:  Perineal Endometriosis with Anal Sphincter Involvement:  Report of a Case.  Dis:Rectum 43:1157-1160, 2000.
• Janicki TI, David LJ, Skaf R:  Massive and Acute Hemoperitoneum Due to Rupture of the Uterine Artery by Erosion from an Endometriotic Lesion.  Fertil Steril 78:879-881, 2002.
• Cravello L, D’Ercole C, Le Treut Y-P, et al:  Hepatic Endometriosis:  A Case Report.
• Thomas EJ, Campbell IG:  Evidence that Endometriosis Behaves in a Malignant Manner.  Gynec Obstet Invest 50:2-10, 2000.
• Martin JD, Hauck AE:  Endometriosis in the Male.  Am Surg 51:426-430, 1985.
• Sampson JA:  Peritoneal Endometriosis Due to the Menstrual Dissemination of Endometrial Tissue into the Peritoneal Cavity.  Am J Obstet Gynecol 14:422, 1927.
• Halme J, Hammond MG, Hulka JF, et al:  Retrograde Menstruation in Healthy Women and in Patients with Endometriosis.  Obstet Gynecol 64:151-154, 1984. 
• Bartosik D, Jacobs SL, Kelly LJ:  Endometrial Tissue in Peritoneal Fluid.  Fertil Steril 46:796-800, 1986.
• Khan-Sabir N, Carr BR:  Endometriosis, Part I:  Diagnosis and Evaluation.  The Female Patient.  29:32-38, 2004.
• Cheesman KL, CheesmanSD, Chatterton RT, et al:  Alterations in Progesterone Metabolism and Luteal Function in Infertile Women with Endometriosis.  Fertil Steril 40:590-595, 1983.
• PittawayDE, Maxson W, Daniell J, et al:  Luteal Phase Defects in Infertility Patients with Endometriosis.  Fertil Steril 39:712-713, 1983.
• Pittaway DE, Wentz AC:  Endometriosis and Corpus Luteum Function:  Is There a Relationship?  J Reprod Med 29:712-716, 1984.
• Ronnberg L, Kauppila A, Rajaniemi H:  Luteinizing Hormone Receptor Disorder in Endometriosis.  Fertil Steril 42:64-68, 1984.
• Dmowski WP, Radwanska E, Binor Z, et al:  Mild Endometriosis an Ovulatory Dysfunction:  Effect of Danazol Treatment on Success of Ovulation Induction.  Fertil Steril 46:784-789, 1986.
• Ayers JWT, Birenbaum DL, Mennon KMJ:  Luteal Phase Dysfunction in Endometriosis:  Elevated Progesterone Levels in Peripheral and Ovarian Veins During the Follicular Phase.  Fertil Steril 47:925-929, 1987.
• Kusuhara K:  Luteal Function in Infertile Patients with Endometriosis.  Am J Obstet Gynecol 167:274-277, 1992.
• McBean JH, Blackman J, Brumsted JR:  Abnormal Ovulation in Women with Endometriosis.  Volume 68, Supplement 1, 22 August 1997, p. S173-S174.
• American Society for Reproductive Medicine:  Revised American Society for Reproductive Medicine Classification of Endometriosis:  1996.  Fertil Steril 67:817-821, 1997.
• D’Hooghe TM, Debrock S, Hill JA, et al:  Endometriosis and Subfertility:  Is the Relationship Resolved?  Sem Reprod Med 21:243-253, 2003.
• Naples JD, Batt RE, Sadijh H:  Spontaneous Abortion Rate in Patients with Endometriosis.  Obstet Gynecol 57:509-512, 1981.
• Groll M:  Endometriosis and Spontaneous Abortion.  Fertil Steril 41:933-935, 1984.
• PittawayDE, Vernon C, Fayez JA:  Spontaneous Abortions in Women with Endometriosis.  Fertil Steril 50:711-715, 1988.
• Olive DL, Franklin RR, Gratkins LV:  The Association Between Endometriosis and Spontaneous Abortion:  A Retrospect of Clinical Study.  J Reprod Med 27:333-338, 1982.
• Metzger DA, Olive DL, Stohs GF, et al:  Association of Endometriosis and Spontaneous Abortion:  Effect of Control Group Selection.  Fertil Steril 45:18-22, 1986.
• Simon C, Gomez E, Mir A, et al:  Glucocorticoid Treatment Decreases Sera Embryo Toxicity in Endometriosis Patients.  Fertil Steril 58:284-289, 1992.

Choroby endometrium

• Murphy LJ, Ghahary A:  Uterine Insulin-like Growth Factor–I:  Regulation of Expression and its Role in Estrogen-induced Uterine Proliferation. Endocr Rev 11:443-453, 1990.
• Julkunen M, Koistinen R, Aalto-Setala K, et al:  Primary Structure of Human Insulin-like Growth Factor-binding Protein/Placental Protein 12 and Tissue Specific Expression of its mRNA.  FEBS Letters 236:295-302, 1988.
• Giudice LC, Dsupin BA, Irwin JC:  Steroid and Peptide Regulation of Insulin-like Growth Factor-binding Proteins Secreted by Human Endometrial Stromal Cells is Dependent on Stromal Differentiation.  J Clin Endocrinol Metab 75:1235-1241, 1992. 
• Kazeer RR:  Insulin Resistance, Insulin-like Growth Factor-I and Breast Cancer:  An Hypothesis.  Int J Cancer 62:403-406, 1995.

Zespół policystycznych jajników (PCOS)

• Stein IF, Leventhal ML: Amenorrhea Associated with Bilateral Polycystic Ovaries.  Am J Obstet Gynecol Page 181-191, 1934.
• Koivunen R, Laatikainen T, Tomas C, et al:  The Prevalence of Polycystic Ovaries in  Healthy Women.  Acta Obstet Gynecol Scand 78:137-141, 1999.
• Adams J, Polson DW, Franks S:  Prevalence of Polycystic ovaries in Women with Anovulation and Idiopathic Hirsutism.  Br Med J 293:355-359, 1986.
• Franks S:  Polycystic Ovary Syndrome:  A Changing Perspective.  Clin Endocrinol 31:87-120, 1989.
• Lanzone A, Fulghesu AM, Andreani CL, et al:  Insulin Secretion in Polycystic Ovarian Disease:  Effect of Ovarian Suppression by GnRH Agonist.  Hum Reprod 5:143-149, 1990.
• Farah L, Azziz R: Polycystic Ovary Syndrome.  The Female Patient.  24: 79-84, 1999.
• Robert Y, Ardaens Y, Dewailly D:  Imaging Polycystic Ovaries.  In:  Kovacs GT (Ed.).  Polycystic Ovary Syndrome.  Cambridge University Press, 2000.
• Moran C, Azziz R: 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia:  The Great Pretender.  In:  Carr BR (Ed) Seminars in Reproductive Medicine 21:295-300, 2003.
• Legro RS, Urbanek M, KunselmanAR, et al:  Self-Selected Women with Polycystic Ovary Syndrome are Reproductively and Metabolically Abnormal and Under Treated.  Fertil Steril 78:51-57, 2002.
• Farah L, Lazenby AJ, Boots LR, et al:  Prevalence of Polycystic Ovarian Syndrome in Women Seeking Treatment from Community Electrologists.  J Repro Med 44:870-874, 1999.
• Fulghesu AM, Ciampelli M, Belosi C, et al:  A New Ultrasound Criterion for the Diagnosis of Polycystic Ovary Syndrome:  The Ovarian Stroma / Total Area Ratio.  Fertil Steril 76:326-331, 2001.
• van Santbrink EJP, Hop WC, Fauser BCJM:  Classification of Normal Gonadotropic Infertility:  Polycystic Ovaries Diagnosed by Ultrasound versus Endocrine Characteristics of Polycystic Ovary Syndrome.  Fertil Steril 67:452-458, 1997.
• Kaleli S, Erel CT, Oral E, et al:  Ovarian Stromal Hypertrophy in Polycystic Ovary Syndrome.  J Repro Med 43:893-897, 1998.
• McCartney CR, EaglesonCA, Marshall JC:  Regulation of Gonadotropin Secretion:  Implications for Polycystic Ovary Syndrome.  Seminars in Reproductive Medicine 20:317-325, 2002.
• Taylor AE, McCourt B, Martin KA, et al:  Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome.  J Clin Endocrinol Metab 82:2248-2256, 1997.
• Kalro BN, Loucks TL, Berga SL:  Neuromodulation in Polycystic Ovary Syndrome.  Infert Reprod Med Clin N Am 14:529-555, 2003.
• Kahsar-Miller MD, Nixon C, Boots LR, et al:  Prevalence of Polycystic Ovary Syndrome (PCOS) in First-Degree Relatives of Patients with PCOS.  Fertil Steril 75:53-58, 2001.
• Legro RS, Strauss JF:  Molecular Progress in Infertility:  Polycystic Ovary Syndrome.  Fertil Steril 78:569-576, 2002.
• Ali AFM, Fateen B, Ezzet A, et al:  Polycystic Ovary Syndrome as an Autoimmune Disease:  A New Concept.  Obstet Gynecol 95:48S, 2000.
• Carmina E, Lobo RA:  Do Hyperandrogenic Women with Normal Menses have Polycystic Ovary Syndrome?  Fertil Steril 71:319-322, 1999.
• Rajaniemi HJ, Ronnberg L, Kauppila A, et al:  Luteinizing Hormone Receptors in Ovarian Follicles of Patients with Polycystic Ovarian Disease.  J Clin Endocrinol Metab 51:1054-1057, 1980.
• Tanaka T, Fujimoto S, Kutsuzawa T:  The Effect of Ovarian Wedge Resection and Incision on Circulating Gonadotropin in Patients with Polycystic Ovarian Disease.  Int J Fertil 23:93-99, 1978.
• Mahesh VB, Toledo SP, Mattar E:  Hormone Levels Following Wedge Resection in Polycystic Ovary Syndrome. Obstet Gynecol 51:64S-69S, 1978.
• Szilagyi A, Rossmanith W, Csermely T, et al: Changes in Circulating Hormone Levels after Ovarian Wedge Resection in Patients with Polycystic Ovary Syndrome. Arch Gynecol Obstet 248:31-35, 1990.
• Campo S, Felli A, Lamanna MA, et al:  Endocrine Changes and Clinical Outcome After Laparoscopic Ovarian Resection in Women with Polycystic Ovaries.  Hum Reprod 8:359-363, 1993.
• Mukherjee, T, Addulla M, Copperman TK:  Increased Incidence of Endometriosis Coexisting with Polycystic Ovary Syndrome in Infertile Patients. Poster presentation 1998 54th Annual Meeting ASRM San Francisco, CA.
• Dahlgren E, Janson PO, Johansson S, et al:  Polycystic Ovary Syndrome and Risk for Myocardial Infarction.  Acta Obstet Gyncol Scand.  71:599-604, 1992.
• Rotterdam ESHRE/ASRM-Sponsored: PCOS Consensus Workshop Group:  Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome.  Fertil Steril 81:19-25, 2004.
• Thacher SS: PCOS:  The Hidden Epidemic.  Perspectives Press, Indianapolis, 2001.
• Gibson M:  Reproductive Health and Polycystic Ovary Syndrome.  Am J Med 98:675-755, 1995.
• Ciampelli M, Lanzone A:  Insulin and Polycystic Ovary Syndrome:  A New Look at an Old Subject.  Gynecol Endocrinol 12:277-292, 1998.
• Gammon M.D., Thomas WD:  Polycystic Ovaries and the Risk of Breast Cancer.  Am J. Epidemiol (134:818-824, 1991).
• Toniolo P, WhittemoreAS:  Re:  ‘Polycystic Ovaries and the Risk of Breast Cancer.’  Am J Epidemiol 136:372-373, 1992.
• Dahlgren E, Johansson S, Lindstedt G, et al:  Women with Polycystic Ovary Syndrome Wedge Resected in 1956 to 1965:  A Long-Term Follow-Up Focusing on Natural History and Circulating Hormones.  Fertil Steril 57:505-513, 1992.
• Solomon CG:  The Epidemiology of Polycystic Ovary Syndrome.  Prevalence and Associated Disease Risks.  Endocrinol Metab Clin North Am 28:247-263, 1999.
• Yarali H, Yildirir A, Aybar F, et al:  Diastolic Dysfunction and Increased Serum Homocysteine Concentrations May Contribute to Increased Cardiovascular Risks in Patients with Polycystic Ovary Syndrome.  Fertil Steril 76:511-516, 2001.
• Mastorakos G, Koliopoulos C, Creatsas G:  Androgen and Lipid Profiles in Adolescents with Polycystic Ovary Syndrome Who were Treated with Two Forms of Combined Oral Contraceptives.  Fertil Steril 77:919-927, 2002.
• Milewicz A, Silber D, Kirschner MA:  Therapeutic Effects of Spironolactone in Polycystic Ovary Syndrome.  Obstet Gynecol 61:429-432, 1983.
• Blum I, Kaufman H, Marilus R, et al: Successful Treatment of Polycystic Ovary Syndrome with Spironolactone or Bromocriptine.  Obstet Gynecol 57:661-665, 1981.
• Dunaif A, Thomas A:  Current Concepts in the Polycystic Ovary Syndrome.  Annu Rev Med 52:401-419, 2001.
• Legos RS, Finegood D, Dunaif A:  A Fasting Glucose to Insulin Ratio is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome.  J Clin Endocrinol Metab. 893:2694-2698, 1998.
• Yildirim B, Sabir N, Kaleli B:  Relation of Intra-Abdominal Fat Distribution to Metabolic Disorders in Non-obese Patients with Polycystic Ovary Syndrome.  Fertil  Steril 79:1358-1364, 2003.
• Nestler JE:  Should Patients with Polycystic Ovarian Syndrome be Treated with Metformin?  An Enthusiastic Endorsement.  Hum Reprod 17:1950-1953, 2002.
• Hansen KA:  Hirsutism:  Options for Treating the Whole Patient. The Female Patient 23:31-38, 1998.
• Schleicher S:  Hirsutism:  Looking Below the Surface.  The Female Patient 25:38-44, 2000.
• Serafini P, Lobo RA:  The Effects of Spironolactone on Adrenal Steroidogenesis in Hirsute Women.  Fertil Steril 44:595-599, 1985.
• Unluhizarci K, Everest H, Bayram F, et al: Comparison of Spironolactone and Spironolactone plus Finasteride in the Treatment of Hirsutism.  Fertil Steril 78:1331-1332, 2002.
• Vigersky RA, Mehlman I, GlassAR, et al:  The Treatment of Hirsute Women with Cimetidine. N Engl J Med page 1042, October 30, 1980.
• Muderris II, Bayram F, Sahin Y, et al:  The Efficacy of 250 mg/day Flutamide in the Treatment of Patients with Hirsutism.  Fertil Steril 66:220-222, 1996.
• Moghetti P, Castello R, Nagri C, et al:  Flutamide in the Treatment of Hirsutism:  Long-Term Clinical Effects, Endocrine Changes, and Androgen Receptor Behavior.  Fertil Steril 65:511-517, 1995.
• Erenus M, Yucelten D, Durmusoglu F, et al:  A Comparison of Finasteride Versus Spironolactone in the Treatment of Idiopathic Hirsutism.  Fertil Steril 68:1000-1003, 1997.
• Ciotta L, Cianci A, Calogero AE, et al:  Clinical and Endocrine Effects of Finasteride, A 5-a Reductase Inhibitor, in Women with Idiopathic Hirsutism.  Fertil Steril 64:299-306, 1995.
• Durmusoglu F, Eranus M:  Efficacy and Safety of Finasteride?  Fertil Steril 68:589, 1997.
• Falsetti L, Gambera A: Comparison of Finasteride and Flutamide in the Treatment of Idiopathic Hirsutism.  Fertil Steril 72:41-46, 1999.
• Attia GR, Raine WE, Carr BR:  Metformin Directly Inhibits Androgen Production in Human Thecal Cells.  Fertil Steril 76:517-524, 2001.
• Mansfield R, Galela R, Brincat M, et al:  Metformin has Direct Effects on Human Ovarian Steroidogensis.  79:956-962, 2003.
• Marca A, Morgante G, Palumbo M, et al: Insulin-Lowering Treatment Reduces Aromatase Activity in Response to Follicle-Stimulating Hormone in Women with Polycystic Ovary Syndrome. Fertil Steril 78:1234-1239, 2002.
• Morin-Papunen LC, Koivunen RM, Ruokonen A, et al:  Metformin Therapy Improves the Menstrual Pattern with Minimal Endocrine and Metabolic Effects in Women with Polycystic Ovary Syndrome. Fertil Steril 69:691-696, 1998.
• Velzquez E, Acosta A, Mendoza SG:  Menstrual Cyclicity After Metformin Therapy and Polycystic Ovary Syndrome.  Obstet Gynecol 90:329-395, 1997.
• Ciampelli M, Lanzone A:  Insulin and Polycystic Ovary Syndrome:  A New Look at an Old Subject.  Gynecol Endocrinol. 12:277-292, 1998.
• Vandermolen DT, Ratts VS, Evans WS, et al:  Metformin Increases the Ovulatory Rate and Pregnancy Rate from Clomiphene Citrate in Patients with Polycystic Ovary Syndrome Who are Resistant to Clomiphene Citrate Alone.  Fertil Steril 75:310-315, 2001.
• Costello MF, Eden JA:  A Systematic Review of the Reproductive System Effects of Metformin in Patients with Polycystic Ovary Syndrome.  Fertil Steril 79:1-13, 2003.
• Lord JM, Flight IHK, Norman RJ:  Metformin in Polycystic Ovary Syndrome:  Systematic Review and Meta-Analysis.  Br Med J 327:1-6, 2003.
• Genazzani AD, Battaglia C, Malavasi B, et al:  Metformin Administration Modulates and Restores Luteinizing Hormone Spontaneous Episodic Secretion and Ovarian Function in Non-Obese Patients with Polycystic Ovary Syndrome.  Fertil Steril 81:114-119, 2004.
• Fulghesu AM, Ciampelli M, Mucj G, et al:  N-acetyl-cysteine Treatment Improves Insulin Sensitivity in Women with Polycystic Ovary Syndrome. Fertil Steril 77:1128-1135, 2002.
• 193.   Ghazeeri G, Kutteh WH, Bryer-Ash M, et al:   Effect of Rosiglitazone on Spontaneous and Clomiphene Citrate-Induced Ovulation in Women with Polycystic Ovary Syndrome. Fertil Steril 79:562-566, 2003.
• 194.   Cateldo NA, Abbasi F, McLaughlin TL, et al:   Improvement in Insulin Sensitivity Followed by Ovulation and Pregnancy in a Woman with Polycystic Ovary Syndrome Treated with Rosiglitazone.  Fertil Steril 76:1057-1059, 2001.
• Nestler JE, Jakubowicz DJ, Reamer P, et al:  Ovulatory and Metabolic Effects of D-chiro-inositol in the Polycystic Ovary Syndrome.  N Engl J Med.  340:1314-1320, 1999.
• Lanzone A, Caruso A, Di Simone N, et al:  Polycystic Ovary Disease, A Risk Factor for Gestational Diabetes?  J Reprod Med 40:312-316, 1995.
• Anttila L, Karjala K, Pentilla T-A, et al:  Polycystic Ovaries in Women with Gestational Diabetes.  Obstet Gynecol 92:13-16, 1998.
• Glueck CJ, Wang P, Kobayashi S, et al:  Metformin Therapy Throughout Pregnancy Reduces the Development of Gestational Diabetes in Women with Polycystic Ovary Syndrome. Fertil Steril 77:520-525, 2002.
• Glueck CJ, Phillips H, Cameron D, et al:  Continuing Metformin Throughout Pregnancy in Women with Polycystic Ovary Syndrome Appears to Safely Reduce First-Trimester Spontaneous Abortion:  A Pilot Study.  Fertil Steril 75:46-52, 2001.
• Fulghesu AM, Lanzone A, Cucinelli F, et al:  Long-Term Naltrexone Treatment Reduces the Exaggerated Insulin Secretion in Patients with Polycystic Ovary Disease.  Obstet Gynecol. 82:191-197, 1993.
• Lanzone A. Fulghesu AM, Fortini A, et al:  Effect of Opiate Receptor Blockade on the Insulin Response to Oral Glucose Load in Polycystic Disease.  Hum Reprod. 6:1043-1049, 1991.
• Lanzone A, Fulghesu AM, Cucinelli F, et al:  Evidence of a Distinct Derangement of Opioid Tone in Hyperinsulinemic Patients with Polycystic Ovary Syndrome:  Relationship with Insulin and Luteinizing Hormone Secretion.  J Clin Endocrinol Metab. 80: 3501-3507, 1995.
• Fulghesu AM, Ciampelli M, Guido M, et al:  Role of Opioid Tone in the Pathophysiology of Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Disease.  Metabolism.  47:1-5, 1998.
• Villa P, Valle D, Mancini A, et al:  Effect of Opioid Blockade on Insulin and Growth Hormone (GH) Secretion in Patients with Polycystic Ovary Syndrome:  The Heterogeneity of Impaired GH Secretion is Related to Both Obesity and Hyperinsulinism.  Fertil Steril 71:115-121, 1999.

Zespół napięcia przedmiesiączkowego  (PMS)

• Giannini AJ, Sullivan B, Sarachene J, et al:  Clonidine in the Treatment of Premenstrual syndrome:  A sub-group study.  J Clin Psychiatry 49:62, 1988.
• Chuong CJ, Coulam CB, Bergstralh EJ, et al:  Clinical Trial of Naltrexone in Premenstrual Syndrome.  Obstet Gynecol 72:332, 1988.
• Halbreich U, Endicott J. Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression. Med Hypotheses. 1981 Aug;7(8):1045-58.

Zaburzenia hormonalne

• Soules MR, Bremner WJ, Dahl KD:  The Induction of Premature Luteolysis in Normal Women Follicular Phase Luteinizing Hormone Secretion and Corpus Luteum Function in the Subsequent Cycle.  Am J Obstet Gynecol 164:989-996, 1991.
• Li CH:  Lipotropin, A New Active Peptide from Pituitary Glands.  Nature 201:924, 1964.
• Loose-Mitchell DS, Stancel GM:  Estrogens and Progestins.  In:  Hardman JG, Limbird LE, Gilman AG (Eds).  Goodman and Gillman’s The Pharmacologic Basis of Therapeutics.  10th Ed 2001.
• Childs GV, Hyde C, Naor Z, et al:  Heterogeneous Luteinizing Hormone and Follicle-Stimulating Hormone Storage Patterns in Sub-types of Gonadotropes Separated by Centrifugal Elutriation.  Endocrinology 113:2120-2128, 1983. 
• Halvorson LM, Chin WW:  Gonadotropic Hormones:  Biosynthesis, Secretion, Receptors and Action.  In:  Yen SSC, Jaffe RB, Barbieri RL, (Eds):  Reproductive Endocrinology:  Physiology, Pathophysiology and Clinical Management.  4th Ed. W.B. Saunders Co, Philadelphia, 1999.
• Childs GV:  Division of Labor Among Gonadotropes.  Vitamin Horm 50:215-286, 1995.
• Childs GV:  Functional  Ultrastructure of Gonadotropes:  A Review.  Curr Top Neuroendocrinol 7:49-97, 1986.
• Schwanzel-Fukuda M, Pfaff DW:  Origin of Luteinizing Hormone-Releasing Hormone Neurons.  Nature 338:161-164, 1989.
• Ziporyn T:  LHRH: Clinical Applications Growing. JAMA 253:469-476, 1985.
• BelchetzPE, Plant TM, Nakai I, et al:  Hypophyseal Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing Hormone.  Science 202:631-633, 1978.
• Crowley WF, McArthur JW:  Stimulation of the Normal Menstrual Cycle in Kallmann’s Syndrome by Pulsatile Administration of Luteinizing Hormone-Releasing Hormone (LHRH).  J Clin Endocrinol Metab. 51:173-175, 1980.
• Hall JE, Whitcomb RW, Rivier JE, et al:  Differential Regulation of Luteinizing Hormone, Follicle-Stimulating Hormone, and Free Alpha-Subunit Secretion from the Gonadotrope by Gonadotropin-Releasing Hormone (GnRH):  Evidence from the Use of Two GnRH Antagonists.  J Clin Endocrinol Metab 70:328-335, 1990.
• Sandow J:  Clinical Applications of LHRH and Its Analogs.  Clin Endocrinol (OXF) 18:571-592, 1983.
• Neill JD, Patton JM, Dailey RA, et al:  Luteinizing Hormone-Releasing Hormone (LHRH) and Pituitary Portal Blood of Rhesus Monkeys:  Relationship to Level of LH Release.  Endocrinology 101:430-434, 1997.
• Levine JE, Ramirez VD:  LHRH Release During the Rat Estrous Cycle and After Ovariectomy, As Estimated with Push-Pull Cannulae.  Endocrinology 111:1439-1448, 1982.
• Knobil E:  The GnRH Pulse Generator.  Am J Obstet Gynecol (Supp). 163:1721-1727, 1990.
• Crowley WF, Filicori M, Spratt DI, Santoro N: The Physiology of Gonadotropin-Releasing Hormone (GnRH) Secretion in Men and Women.  Recent Progress in Hormone Research.  Academia Press, 41:473, 1985.
• Marshall JC, Kelch RP:  Gonadotropin-Releasing Hormone:  Role of Pulsatile Secretion in the Regulation of Reproduction.  N Engl J Med 315:1459-1468, 1986.
• Yen SSC, Quigley ME, Reid RL, et al:  Neuroendocrinology of Opioid Peptides and their Role of Gonadotropin and Prolactin Secretion.  Am J Obstet Gynecol 152:485-493, 1985.
• Young JR, Jaffe RB:  Strength-Duration Characteristics of Estrogen Effects on Gonadotropin Response to Gonadotropin-Releasing Hormone in Women.  J Clin Endocrinol Metab 42:432-442, 1976.
• Van Vugt DA, LamNY, Ferin M:  Reduced Frequency of Pulsatile Luteinizing Hormone Secretion in the Luteal Phase of the Rhesus Monkey:  Involvement of Endogenous Opiates.  Endocrinology 315:1095-1101, 1984.
• Dye RB, Rabinovici J, Jaffe RB:  Inhibin and Activin in Reproductive Biology.  Obstet Gynecol Surv 47:173-185, 1992.
• de Winter JP, ten Dijke P, de Vries CJ, et al:  Follistatins Neutralize Activin Bioactivity by Inhibition of Activin Binding to Its Type II Receptors.  Mol Cell Endocrinol 116:105-104, 1996. 
• Muenier H, Rivier C, Evans RM, et al:  Gonadal and Extragonadal Expression of Inhibin Alpha, Beta A, and Beta B Subunits in Various Tissues Predicts Diverse Functions.  Proc Natl Acad Sci USA.  85:247-251, 1988.
• Ropert JF Quigley ME, Yen SSC:  Endogenous Opiates Modulate Pulsatile Luteinizing Hormone Release in Humans.  J Clin Endocrinol Metab 52:583, 1981.
• Hughes J, Smith TW, Kosterlitz HW, et al:  Identification of Two Related Penta Peptides from the Brain with Potent Opiate Agonist Activity.  Nature 258:577, 1975.
• Goldstein A, Tachibana S, Lowney LI, et al:  Dynorphin (1-13) – An Extraordinary Potent Opioid Peptide. Proc Natl Acad Sci USA.  76:6666, 1979.
• Morley JE:  The Endocrinology of the Opiates and Opioid Peptides.  Metabolism 30:195, 1981.
• Grossman A, Rees LH:  The Neuroendocrinology of Opioid Peptides.  Br Med Bul 39:83, 1983.
• Ferin M, vanVugt D, Wardlaw SL:  The Hypothalamic Control of the Menstrual Cycle and the Role of Endogenous Opioid Peptides.  Recent Prag Horm Res 40:441, 1984.
• Wehrenberg WB, Wardlaw SL, Frantz AG, et al:  Beta-endorphin in Hypophyseal Portal Blood:  Variations Throughout the Menstrual Cycle.  Endocrinology 111:879, 1982.
• Blankstein J, Reyes FI, Winter JSD, et al:  Endorphins and the Regulation of the Human Menstrual Cycle.  Clin Endocrinol (OXF) 14:287, 1981. 
• Chuong CJ, Coulam CB, Kao PC, et al:  Neuropeptide Levels in Premenstrual Syndrome.  Fertil Steril 44:760, 1985.
• Facchinetti F, Martignoni E, Petraglia F, et al:  Premenstrual Fall of Plasma Beta-endorphin in Patients with Premenstrual Syndrome.  Fertil Steril 47:570, 1987.
• Wilkes MM, Watkins WB, Stewart RD, et al:  Localization and Quantitation of Beta-endorphin in Human Brain and Pituitary.  Neuroendocrinology 30:113, 1980.
• Watkins WB, Yen SSC, Moore RY:  Presence of Beta-endorphin-like Immunoreactivity in the Anterior Pituitary Gland of Rat and Man and Evidence for the Differential Localization with ACTH.  Cell Tissue Res. 215:577, 1981.
• Seifer DB, Collins RL:  Current Concepts of Beta-endorphin Physiology in Female Reproductive Dysfunction.  Fertil Steril 54:757-771, 1990.
• Guillemin R, Vargo T, Rossier J, et al:  Beta-endorphin and Adrenocorticotropin are Secreted Concomitantly by the Pituitary Gland.  Science 197:1367, 1977.
• Barraclough CA, Sawyer CH:  Inhibition of the Release of Pituitary and Ovulatory Hormone in the Rat by Morphine.  Endocrinology 57:329, 1955.
• Pang CN, Zimmerman E, Sawyer CH:  Morphine Inhibition of the Preovulatory Surges of Plasma-Luteinizing Hormone and Follicle-Stimulating Hormone in the Rat.  Endocrinology 101:1726, 1977.
• Santen RJ, Sofsky J, Bilik N, et al:  Mechanism of Action of Narcotics in the Production of Menstrual Dysfunction in Women.  Fertil Steril 26:538, 1975.
• Goldstein A, Lowney LI, Pal BK:  Stereospecific and Non-specific Interaction of the Morphine Congener Levorphanol in Subcellular Fractions of Mouse Brain.  Proc Natl Acad Sci USA. 68:1742, 1971.
• Loriaux L, Nieman S:  Stress and Reproduction:  The Role of Cortisol:  In:  Yen SSC, Vale WW (Eds).  Neuroendocrine Regulation of Reproduction.  Serono Symposia 307-311, 1990.
• Gruhn JG, Kazer RR:  Hormonal Regulation of the Menstrual Cycle:  The Evolution of Concepts.  Plenum Medical Book Company, New York, 1989.
• Abuzeid MI, Wiebe RH, Aksel S, et al:  Evidence for a Possible Cytosol Estrogen Receptor Deficiency in Endocervical Glands of Infertile Women with Poor Cervical Mucus.  Fertil Steril 47:101-107, 1987. Borenstein R, Shoham Z, Yemini M, et al:  Tamoxifen Treatment in Women with Failure of Clomiphene citrate Therapy.  Aust NZ J Obstet Gynaecol 29:173-175, 1989.
• Goto S, Takakura K, Nakanishi K, et al:  Efficacy of Clomiphene Citrate and Cyclofenil for Infertile Women with Normal Ovulatory Cycles.  Fertil Steril 76:409-411, 2001.  
• Yong EL, Glasier A, Hillier H, et al:  Effect of Cyclofenil on Hormonal Dynamics, Follicular Development and Cervical Mucus in Normal and Oligomenorrheic Women.  Hum Reprod 7:39-43, 1992.

Inne przyczyny niepłodności

• Burns LH, Covington SH:  Infertility Counseling:  A Comprehensive Handbook for Clinicians.  Parthenon Publishing.  New York, 2000.
• Can Fam Physician. 2012 May;58(5):e267-74. Natural procreative technology for infertility and recurrent miscarriage: outcomes in a Canadian family practice. ThamE, Schliep K, StanfordJ. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352813/?tool=pubmed
• Halbreich U, Endicott J: Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression. Med Hypotheses. 1981 Aug;7(8):1045-58.
• Stanks GC, Grimes EW:  Clinical Management of Infertility due to Multiple Causes.  Sem Reprod Endocrin 3:185-192, 1985.
• Jansen RPS:  Elusive Fertility: Fecundability and Assisted Conception in Perspective. Fertil Steril 64: 252-254, 1995.
• Wassersk Sewall G, Soules MR: Psychosocial Stress as a Cause of Infertility.  Fertil Steril 59: 658-689, 1993.
• Dickey RP, Taylor SN, Rye PH, et al: Infertility is a Symptom Not a Disease.  Fertil Steril 74: 398, 2000.
• Saracoglu FO, Mungan T, Tanzer F:  Salpingitis Isthmica Nodosa in Infertility and Ectopic Pregnancy.  Gynecol Obstet Invest 34:202-205, 1992.
• Hilgers TW and Yeung P: Intratubal Pressure Before and After Transcervical Catheterization of the Fallopian Tubes.  Fertil Steril 72:174-178, 1999.
• Sulak PJ:  Sexually Transmitted Diseases.  Seminars in Reproductive Medicine (Carr BR, Ed.) 21:399-413, 2003.
• Vigil P, Tapia A, Zacharis S, et al:  First-Trimester Pregnancy Loss and Active Chlamydia Trachomatis Infection:  Correlation and Ultrastructural Evidence.  Andrologia 34:373-378, 2002.
• Westrom L, Joesoef R, Reynolds G, et al:  Pelvic Inflammatory Disease and Fertility:  A Cohort Study of 1,844 Women with Laparoscopically-Verified Disease and 657 Control Women with Normal Laparoscopy Results.  Sex Transm Dis 19:185-192, 1992.
• Center for Disease Control and Prevention.  Screening Tests to Detect Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections – 2002.  MMWR 51 (No. RR-15) 2002.
• Stamm WE, Guinan ME, Johnson C, et al:  Effective Treatment Regimens for Neisseria Gonorrhoeae on Simultaneous Infection with Chlamydia Trachomatis.  N Engl J Med 310:545-549, 1984.
• Rees E.  Treatment of Pelvic Inflammatory Disease.  Am J Obstet Gynecol 138:1042-1047, 1980.
• Sciarra JJ:  Sexually Transmitted Diseases:  Global Importance.  Int J Gynec Obstet 58:107-119, 1997.
• Alexander LL, Cates JR, Herndon N, Ratcliffe JF:  Sexually Transmitted Diseases in America:  How Many Cases and at What Cost?  Prepared for the Kaiser Family Foundation by, American Social Health Association, December 1998.
• Fulghesu AM, Ciampelli M, Fortini A, et al:  Effect of Opioid Blockade on Insulin Metabolism in Polycystic Ovarian Disease.  Hum Reprod 10:2253-2257, 1995.
• Ipp E, Dobbs R, Unger RH:  Morphine and β-Endorphins Influence the Secretion of the Endocrine Pancreas.  Nature. 276:190-191, 1978.
• Secreto G, Zumoff B:  Abnormal Production of Androgens in Women with Breast Cancer.  Anticancer Res 14:2113-2117, 1994.
• Craig LB, Ke RW, Kutteh WH:  Increased Prevalence of Insulin Resistance in Women with a History of Recurrent Pregnancy Loss.  Fertil Steril 78:487-490, 2002.
• Bedaiwy MA, Miller KF, Goldberg JM, et al:  Effect of Metformin on Mouse Embryo Development.  Fertil Steril 76:1078-1079, 2001.
• Giugliano D, Ceriello A, Salvatore T, et al:  β-Endorphin Infusion Restores Acute Insulin Responses to Glucose in Type 2 Diabetes Mellitus.  J Clin Endocrinol Metab 64:944-948, 1987.
• Givens JR, Kurtz BR, Kitabchi AE, et al:  Reduction of Hyperinsulinemia and Insulin Resistance by Opiate Receptor Blockade.  J Clin Endocrinol Metab. 64:377-382, 1987.
• Bahamondes L, Bueno GJR, Hardy E, et al:  Identification of Main Risk Factors for Tubal Infertility. Fertil Steril 61:478-482, 1994.
• Coulam CB, Annegers JF, Kranz JS:  Chronic Anovulation Syndrome and Associated Neoplasia.  Obstet Gynecol 61:403-407, 1983.
• Kaaks R:  Nutrition, Hormones and Breast Cancer:  Is Insulin the Missing Link?  Cancer Causes Control.  7:605-625, 1996.
• Schally AV, Kastin AJ, Arimura A:  The Hypothalamus and Reproduction.  Am J Obstet Gynecol 114:423, 1972.
• Harlow BL, Signorello LB, Hall JE, et al:  Reproductive Correlates of Chronic Fatigue Syndrome.  Am J Med. 105(3A):94S-99S, 1998.

Nowotwory piersi i jajnika

• WhittemoreAS, Harris R, Itnyer J, et al:  Characteristics Relating to Ovarian Cancer Risks:  Collaborative Analysis of 12 U.S. Case-Controlled Studies.  II.  Invasive Epithelial Ovarian Cancers in White Women.  Am J Epidem 136:1184-1203, 1992.
• Rossing MA, Daling JR, WeissNS, et al:  Ovarian Tumors in a Cohort of Infertile Women.  N Engl J Med 331:771-776, 1994.  This is a second article which introduced the topic.  Prolonged use of clomiphene may increase the risk of a borderline or invasive ovarian tumor.
• Potashnik G, Lerner-Geva L, Genkin L, et al:  Fertility Drugs and the Risk of Breast and Ovarian Cancers:  Results of a Long-Term Followup Study.  Fertil Steril 71:853-859, 1999.
• Modan B, Ron E, Lerner-Giva L, et al:  Cancer Incidence in a Cohort of Infertile Women.  Am J Epidem 147:1038-1042, 1998.
• Venn A, Watson L, Lumley J, et al:  Breast and Ovarian Cancer Incidence After Infertility and In Vitro Fertilization.  Lancet 346:995-1000, 1995. 
• Ness RB, Cramer DW, GoodmanMT, et al:  Infertility, Infertility Drugs and Ovarian Cancer:  A Pooled Analysis of Case-Control Studies.  Am J Epidemiol 155:217-224, 2002.

Leczenie niepłodności

Indukcja owulacji

• Bulun SE:  Ovulation Induction of Women with Infertility:  A New Indication for Aromatase Inhibitors.  Fertil Steril 80:1338, 2003. 
• Mitwally MFM, Casper RF:  SingleDose Administration of the Aromatase Inhibitor, Letrozole:  A Simple and Convenient Effective Method of Ovulation Induction.  Fertil Steril 76 (Suppl 1):594-595, 2001. Harlap S:  Ovulation Induction and Congenital Malformations.  Lancet 2:961, 1976.
• Correy JF, Marsden DE, Schokman FCM:  The Outcome of Pregnancy Resulting from Clomiphene-Induced Ovulation.  Aust NZ – J Obstet Gynaecol  22:18, 1982.
• Hack M, Brish M, Serr DM, et al:  Pregnancy after Induced Ovulation.  Followup of Pregnancies in Children Born after Clomiphene Citrate.  JAMA 220:1329, 1972. 
• Gomel V:  Salpingostomy by Microsurgery.  Fertil Steril 29:380-387, 1978.
• Kistner RW:  Sequential Use of Clomiphene Citrate and Human Menopausal Gonadotropin in Ovulation Induction.  Fertil Steril 27:72-82, 1976.
• March CM:  Ovulation Induction.  J Reprod Med 38:335-346, 1993.
• Kennedy JL, Adashi EY:  Ovulation Induction.  Obstet Gynecol Clin North Am 14:831-864, 1987. 
• Greenblatt RB, Barfield WE, Jungek EC, et al:  Induction of Ovulation with MRL/41.  JAMA 178:101, 1961.
• Charles D:  M.R.L. 41 in the Treatment of Secondary Amenorrhea and Endometrial Hyperplasia.  Lancet 2:278, 1962. 
• Greenblatt RB, Roy S, Mahesh VB, et al:  Induction of Ovulation.  Am J Obstet Gynecol 84:900, 1962.
• Adashi EY:  Clomiphene Citrate – Initiated Ovulation:  The State of the Art.  In:  Wallach EE, Zacur HA (Eds).  Reproductive Medicine and Surgery.  Mosby, St. Louis, 1995. Casper RF:  Letrozole:  Ovulation or Superovulation? Fertil Steril 80:1335-1337, 2003.
• TourgemanDE:  Ovulation Induction is not the Same as Superovulation:  The Effect of Selective Estrogen Receptor Modulators and Aromatase Inhibitors.  80:1333-1334, 2003.
• Mitwally MF, Casper RF:  Using Aromatase Inhibitors to Induce Ovulation in Breast CA Survivors.  Contemporary OB/GYN.  49:73-83, 2004.
• Healey S, Tan SL, Tulandi T, et al:  Effects of Letrozole on Superovulation with Gonadotropins in Women Undergoing Intrauterine Insemination.  Fertil Steril 80:1325-1329, 2003.
• Kilic-Okman T, Kucuk M, Altaner S:  Comparison of the Effects of Letrozole in Clomiphene Citrate on Ovarian Follicles, Endometrium and Hormone Levels in the Rat.  Fertil Steril 80:1330-1332, 2003. 
• Healey S, Tan SL, Biljan MM, et al:  Letrozole and Gonadotropins:  What is the Ideal Patient Protocol?  Fertil Steril 80:1339, 2003.
• Mitwally MFM, Casper RF:  Aromatase Inhibition Improves Ovarian Response to Follicle-Stimulating Hormone and Poor Responders.  Fertil Steril 77:776-780, 2002.  In this preliminary report, we demonstrate a potential benefit of aromatase inhibition for improving ovarian response to FSH in poor responders.
• Ludwig M, Doody KG, Doody KM:  Use of Recombinant Human Chorionic Gonadotropin in Ovulation Induction.  Fertil Steril 79:1051-1059, 2003.
• Mitwally MFM, Casper RF:  Use of an Aromatase Inhibitor for Induction of Ovulation in Patients with an Inadequate Response to Clomiphene Citrate.  Fertil Steril 75:305-309, 2001.
• Mitwally MFM, Casper RF:  Aromatase Inhibitors in Ovulation Induction.  In:  Aromatase:  Update and New Roles in Reproductive Disease.  Carr BR, Bulun SE (Eds) Sem Reprod Med 22:61-78, 2004. 
• Boostanfar R, Jain JK, Mishell DR:  A Prospective Randomized Trial Comparing Clomiphene citrate with Tamoxifen Citrate for Ovulation Induction.  Fertil Steril 75:1024-1026, 2001. Tsuiki A, Uehara S, Kyono K, et al:  Induction of Ovulation with an Estrogen Antagonist, Tamoxifen.  Tohoku J Exp Med 144:21-31, 1984.
• Tajima C:  Endocrine Profiles in Tamoxifen-Induced Conception Cycles.  Fertil Steril 42:548-553, 1984.
• Tajima C, Fukushima T:  Endocrine Profiles in Tamoxifen-Induced Ovulatory Cycles.  Fertil Steril 40:23-30, 1983. 
• Messinis IE, Nillius SJ:  Comparison Between the Tamoxifen and Clomiphene for Induction of Ovulation.  Acta Obstet Gynecol Scand 61:377-379, 1982. 
• American Society for Reproductive Medicine.  Practice Committee Report:  A Technical Bulletin.  Induction of Ovarian Follicle Development and Ovulation with Exogenous Gonadotropins.  American Society for Reproductive Medicine,  Birmingham, AL, 1998.
• Yagel S, Ben-Chetrit A, Anteby E, et al:  The Effect of ethinyl estradiol on Endometrial Thickness and Uterine Volume During Ovulation Induction by Clomiphene Citrate.  Fertil Steril 57:33-36, 1992.
• Gompel A, Mauvais-Jarvis P:  Induction of Ovulation with Pulsatile GnRH and Hypothalamic Amenorrhea.  Hum Reprod 3:473-477, 1988.
• Hilgers TW:  The Use of Preovulatory Subcutaneous “Booster” GnRH (Self-Administered) for Ovulation Induction.  Symposium on Modes of Action on GnRH and GnRH Analogs, February 26-March 2, 1991, Scottsdale, AZ.
• Hammond MG, Halme JK, Talbert LM:  Factors Affecting the Pregnancy Rate in Clomiphene Citrate Induction of Ovulation.  Obstet Gynecol 62:196-202, 1983.
• DaleyDC, Walters CA, Soto-Albors CE, et al:  A Randomized Study of Dexamethasone and Ovulation Induction with Clomiphene Citrate.  Fertil Steril 41:844-848, 1984.

Rola płynu otrzewnego

• Haney AF, Muscato JJ, Weinberg JB:  Peritoneal Fluid Cell Populations in Infertility Patients.  Fertil Steril 35:696-697, 1981.
• Gerrity M, Rinehart JS, Shapiro SS:  The Effect of Human Peritoneal Fluid on Embryonic Development.  Annual Meeting of the American Fertility Society.  Abstract #58, 1985.
• Umesaki N, Uda S, Kawabata M, et al:  Significance of Peritoneal Macrophages on Fertility in Mice.  Am J Obstet Gynecol 167:261-264, 1992.
• Sueldo CE, Lambert H, Steinleitner AJ, et al:  Effect of Peritoneal Fluid on MUrine Sperm-Ova Interaction.  Annual Meeting of the American Fertility Society.  Abstract #23, 1986.

Terapia farmakologiczna

• Stanford JB, Mikolajczyk RT, Lynch CD, Simonsen SE. Source: Department of Family and Preventive Medicine, Division of Public Health, University of Utah, Salt Lake City, Utah, USA. Fertil Steril. 2010 May 1;93(7):2175-81. Epub 2009 Mar 28.
• Bayer SR, Alper MM, PenziasAS:  The Boston IVF Handbook of Infertility.  Parthenon Publishing Group. Boca Raton, 2002.
• Kolstad HA, Bonde JP, HjollundNH et al: Menstrual Cycle Pattern and Fertility: A Prospect of Follow-up Steady of Pregnancy of early Embryonal Loss in 295 Couples Who Were Planning Their First Pregnancy.  Fertil Steril 71: 490-496, 1999. Nakamura Y, Ono M, Yoshida Y, et al:  The Effects of Clomiphene Citrate on the Endometrial Thickness of an Echogenic Pattern of the Endometrium.  Fertil Steril 67:256-260, 1997.
• Eden JA, Place J, Carter GD, et al:  The Effect of Clomiphene Citrate on Follicular Phase Increase on Endometrial Thickness and Uterine Volume.  Obstet Gynecol 73:187-190, 1989.
• Check JH, Diettreich C, Luri D:  The Effect of Consecutive Cycles of Clomiphene Citrate on Endometrial Thickness and Echo Pattern.  Obstet Gynecol 86:341-345, 1995. 
• Hilgers TW, Daly KD, Prebil, AM and Hilgers SK:  Cumulative Pregnancy Rates in Patients with Apparently Normal Fertility in Fertility-Focused Intercourse.  J Repro Med. 10:864-866, 1992.
• Fukushima T, Tajima C, Fukuma K, et al:  Tamoxifen in the Treatment of Infertility Associated with Luteal Phase Deficiency.  Fertil Steril 37:755-761, 1982.
• Fukushima T, Maeyama M:  Action of Tamoxifen on Folliculogenesis in the Menstrual Cycle of Infertile Patients.  Fertil Steril 40:210-214, 1983.
• Rouman FJME, Doesburg WH, Rolland R:  Treatment of Infertile Women with a Deficient Postcoital Test with Two Antiestrogens:  Clomiphene and Tamoxifen.  Fertil Steril 41:237-243, 1984.
• Schaumburg H, Kaplan J, Windebank A, et al:  Sensory Neuropathy from Pyridoxine Abuse:  A New Mega-Vitamin Syndrome.  N Engl J Med 309:445-448, 1983.
• Parry GJ, BredesenDE:  Sensory Neuropathy with Low-Dose Pyridoxine.  Neurology 35:1466-1468, 1985.
• BergerAR, Schaumburg HH, Schroeder C, et al:  Dose Response, Coasting, and Differential Fiber Vulnerability in Human Toxic Neuropathy:  A Prospective Study of Pyridoxine Neurotoxicity.  Neurology 42:1367-1370, 1992. 
• Neely JL, Abate M, Swinker M, et al:  The Effect of Doxycycline on Serum Levels of Ethinyl Estradiol, Norethindrone And Endogenous Progesterone.  Obstet Gynecol 77:416-420, 1991.
• Zieman M, Nelson A: Combination OCs and Prescribed Antibiotics.  The Female Patient.  27:40-41, 2002.
• Martin F, Peltonen J, Laatikainen T, et al:  Excretion of Progesterone Metabolites and Estriol in Faeces from Pregnant Women During Ampicillin Administration.  J Steroid Biochem 6:1339-1346, 1975.
• Hilgers TW:  Successful Pregnancies in Kallmann Syndrome Using Pulsatile IV GnRH.  Symposium on Modes of Action of GnRH and GnRH. Analogs, February 26-March 2, 1991, Scottsdale, AZ.
• Check JH, Diettreich C, Nowroozi K, et al:  Comparison of Various Therapies for the Luteinized Unruptured Follicle Syndrome.  Int J Fertil 37:33-40, 1992.
• The Practice Committee of the American Society for Reproductive Medicine.  Use of Clomiphene Citrate in Women.  Fertil Steril 80:1302-1308, 2003.  
• Purvin V:  Visual Disturbance Secondary to Clomiphene Citrate.  Arch Ophthalmol 1130:482-484, 1995.
• Gerli S, Gholami H, Manna A, et al:  Use of Ethinyl Estradiol to Reverse the Anti-Estrogenic Effects of Clomiphene citrate in Patients Undergoing Intrauterine Insemination:  A Comparative, Randomized Study.  Fertil Steril 73:85-89, 2000.
• Barrett CTH, Hakim CA:  Low-Dosage Clomiphene Therapy in the Treatment of Infertility Due to Defective Ovulation.  S Afr Med J 48:1456-1458, 1974.
• Biljan MM, Mahutte NG, Tulandi T, et al:  Prospective Randomized Double-Blind Trial of the Correlation Between Time of Administration and Anti-Estrogenic Effects of Clomiphene Citrate on Reproductive End Organs.  Fertil Steril 71:633-638, 1999.
• Lobo RA, Paul W, March CM, et al:  Clomiphene and Dexamethasone in Women Unresponsive to Clomiphene Alone.  Obstet Gynecol 60:497-501, 1982.
• Isaacs JD, Lincoln SR, Cowan BD:  Extended Clomiphene Citrate (CC) and Prednisone for the Treatment of Chronic Anovulation Resistant to CC alone.  Fertil Steril 67:641-643, 1997.
• Soto-Albors C, DalyDC, Ying Y-K:  Efficacy of Human Menopausal Gonadotropins as Therapy for Abnormal Cervical Mucus.  Fertil Steril 51:58-62, 1989. 
• Filicori M, Cognigni GE, Tabarelli C, et al:  Stimulation and Growth of Antral Ovarian Follicles by Selective LH Activity Administration in Women.  J Clin Endocrinol Metab 87:1156-1161, 2002. 
• Filicori M, Cognigni GE, Taraborreli S, et al:  Intracytoplasmic Sperm Injection Pregnancy after Low-Dose Human Chorionic Gonadotropin Alone to Support Ovarian Folliculogenesis.  Fertil Steril 78:414-416, 2002.
• Maxson WS, PittawayDE, Herbert CM, et al:  Antiestrogenic Effect of Clomiphene Citrate:  Correlation with Serum Estradiol Concentrations.  Fertil Steril 42:356-359, 1984.
• Massai MR, de Ziegler D, Lesorbre V, et al:  Clomiphene Citrate Affects Cervical Mucus and Endometrial Morphology Independently of the Changes in Plasma Hormonal Levels Induced by Multiple Follicular Recruitment.  Fertil Steril 59:1179-1186, 1993.
• Nakai Y, Plant TM, Hess DL, et al:  On the Sites of the Negative and Positive Feedback Actions of Estradiol in the Control of Gonadotropin Secretion in the Rhesus Monkey.  Endocrinology 102:1008, 1978.
• Knobil E, Plant TM, Wildt L, et al:  Control of the Rhesus Monkey Menstrual Cycle:  Permissive Role of Hypothalamic Gonadotropin-Releasing Hormone.  Science 270:1371, 1980.
• Leyendecker G, Wildt L, Hansmann M:  Pregnancies Following Chronic Intermittent (Pulsatile) Administration of Gn-Rh by Means of a Portable Pump (“Zyklomat”) – A New Approach to the Treatment of Infertility and Hypothalamic Amenorrhea.  J Clin Endocrinol Metab.  51:1214, 1980.
• Dodge ST, Strickler, Keller DW:  Ovulation Induction with Low Doses of Clomiphene Citrate.  Obstet Gynecol 67:63S-65S, 1986.
• Shalev J, Goldenberg M, Kukia E, et al:  Comparison of Five Clomiphene Citrate Dosage Regimens:  Follicular Recruitment and Distribution in the Human Ovary.  Fertil Steril 52:560-563, 1989.
• Council on Drugs.  American Medical Association.  Evaluation of a New Ovulatory Stimulating Agent:  Clomiphene Citrate (Clomid).  JAMA 206:635-636, 1968. 
• Adashi EY, Rock JA, Shapp KC, et al:  Gestational Outcome of Clomiphene-Related Conceptions.  Fertil Steril 31:620,1979.
• Ahlgren M, Kallen B, Rannevik G:  Outcome of Pregnancy after Clomid Therapy.  Acta Obstet Gynecol Scand 53:371, 1976. 
• Insler V, Zakut H, Serr DM:  Cycle Pattern and Pregnancy Rate Following Clomiphene-Estrogen Therapy.  Obstet Gynecol 41:602, 1973. 
• Karow WG, Payne SA:  Pregnancy after Clomiphene Citrate Treatment.  Fertil Steril 19:351, 1968.
• Kurachi K, Aono T, Minagawa J, et al:  Congenital Malformation of Newborn Infants after Clomiphene-Induced Ovulation.  Fertil Steril 40:187, 1983. 
• Asch RH, Greenblatt RB:  Update on the Safety and Efficacy of Clomiphene Citrate as a Therapeutic Agent.  J Reprod Med 17:175, 1976.
• Kerin JF, Liu JH, Phillipou G, et al:  Evidence for a Hypothalamic Site of Action of Clomiphene Citrate in Women.  J Clin Endocrinol Metab 61:265, 1985.
• Greenblatt RB, Barfield WE, Jungck EC, et al:  Induction of Ovulation with MRL/41:  Preliminary Report.  JAMA 178:127-130, 1961.
• Greenblatt RB:  Chemical Induction of Ovulation.  Fertil Steril 12:402-404, 1961. 
• Smith OW, Smith GV, Kistner RW:  Action of MER-25 and of Clomiphene on the Human Ovary.  JAMA.  184:122-130, 1963.
• Naville AH, Kistner RW, Wheatley RE, et al:  Induction of Ovulation with Clomiphene Citrate.  Fertil Steril 15:290-309, 1964. 
• Rivo E, Rock J:  The Clinical Use of Clomiphene Citrate.  Pac Med Surg 413-420, Nov.-Dec. 1965.
• Jones GS, Moraes-Ruehsen MD:  Clomiphene Citrate for Improvement of Ovarian Function.  Am J Obstet Gynecol 99:814, 1967.
• Kistner R:  Further Observations on the Effects of Clomiphene Citrate in Anovulatory Females.  Am J Obstet Gynecol 92:380, 1965.
• Lamm EJ, Guderian AM:  Clinical Effects of Clomiphene in Anovulation.  Obstet Gynecol 28:505, 1966.
• MacGregor AH, Johnson JE, BundeCA:  Further Clinical Experience with Clomiphene Citrate.  Fertil Steril 19:616, 1968.
• Puebla RA, Greenblatt RB:  Clomiphene Citrate in the  Management of Ovulatory Uterine Bleeding.  J Clin Endocrinol 24:863, 1964. 
• Roy S, Greenblatt RB, Mahesh VB, et al:  Clomiphene Citrate:  Further Observations on its Use in Induction of Ovulation in the Human and on its Mode of Action.  Fertil Steril 14:575-594, 1963.
• Whitelaw MJ, Grams LR, Stamm WJ:  Clomiphene Citrate:  Its Uses and Observations on its Probable Action.  Am J Obstet Gynecol 90:355, 1964. 
• BelchetzPE, Plant TM, Nakai I, et al:  Hypophyseal Responses to Continuous and Intermittent Delivery of Hypothalmic Gonadotropin-Releasing Hormone. Science 202:631, 1978. 
• Practice Committee Report.  Salpingectomy for Hydrosalpinx Prior to IVF.  American Society for Reproductive Medicine and Society of Reproductive Surgeons.  July 2001.
• Gemzell C, Diczfalusy E, Tillinger G:  Clinical Effects of Human Pituitary Follicle-Stimulating Hormone (FSH).  J Clin Endocrinol Metab 18:1333, 1958. 
• Donini P, Puzzvoli D, Montezemolo R:  Purification of Gonadotropin from Human Menopausal Urine.  Acta Endocrinol 45:321, 1964.
• Gurgan T, Urman B, Yarali H, et al:  Salpingoscopic Findings in Women with Occlusive and Nonocclusive Salpingitis Isthmica Nodosa.  Fertil Steril 61:461-463, 1994.
• American Fertility Society.  The American Fertility Society Classifications of Adnexal Adhesions, Distal Tubal Occlusion, Tubal Occlusion Secondary to Tubal Ligation, Tubal Pregnancies, Müllerian Anomalies And Intrauterine Adhesions.  Fertil Steril 49:944-955, 1988.
• Puttemans PJ, BrosensIA, Delattin PH, et al:  Salpingoscopy versus Hysterosalpingography in Hydrosalpinges.  Hum Reprod 2:535-540, 1987.
• Marana R, Rizzi M, Muzii L, et al:  Correlation Between the American Fertility Society Classifications of Adnexal Adhesions and Distal Tubal Occlusion, Salpingoscopy and Reproductive Outcome in Tubal Surgery.  Fertil Steril 64:924-929, 1995.
• Marana R, Catalano GF, Muzii L, et al:  The Prognostic Role of Salpingoscopy in Laparoscopic Tubal Surgery.  Hum Reprod 14:  2991-2995, 1999.

Zaburzenia owulacji

• Yong PY, Baird DT, Thong KJ, McNeilly AS, Anderson RA. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod 18:35,2003.
• Lass A, Silye R, Abrams D-C, Krausz T, Hovatta O, Margara R, Winston RML. Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum Reprod 12: 1028,1997.
• Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremmer WJ, Soules MR. Reproducitve aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older woman. J Clin Endocrin Metab 81:1038;1996.
• Grynnerup AG, Lindhard A, Sorensen S. The role of anti-Müllerian hormone in female fertility and infertility - an overview. Acta Obstet Gynecol Scand. 2012 Nov;91(11):1252-60.
• Santoro N: Mechanisms of premature ovarian failure. Ann Endocrinol 2003, 64:87-92.
• Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS: Characterization of idiopathic premature ovarian failure. Fertil Steril 1996, 64:337-341
• Simpson JL, Rajkovic A: Ovarian differentiation and gonadal failure. Am J Med Genet 1999, 89:186-200.
• Iguchi H, Kato K, Ibayashi H. Are dependent reduction in serum-melatonin concentration in healthy human subjects. J Clin Endocrinol Metab 1982; 55: 27.

Hormony

• CA. Clarke, SL. Glaser, CS. Uratsu, JV. Selby i inni. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol 24 (33), s. e49-50, Nov 2006.

DHEA

• Mamas L, Mamas E (February 2009). Premature ovarian failure and dehydroepiandrosterone. Fertil. Steril. 91 (2): 644–6.
• Gleicher N, Weghofer A, Barad DH (2010). Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod. Biol. Endocrinol. 8: 140.

   

Melatonina

• Bellipani G, Bianchi P, Pierpaoli W, et al. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo colntrolled study. Exp Gerontol 2001; 36 (2): 297-310.
• Cagnaci A, Paoletti AM, Soldani R, et al. Melatonin enhances the luteinizing hormone and follicle-stilulation hormone response to gonadotropin-releasing hormone in the follicular, but not in the luteal menstrual phase. J Clin Endocrinolo Metab 1995; 80 (4): 1095-9.
• Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A reviev of the multiple actions of melatonin on the immune system. Endocrine 2005; 27 (2): 189-200.
• Fisher TW, Zmijewski MA, Zbytek B, et al. Oncostatic effects of the indole melatonin and expression of its cytosolic and muclear receptors in cultured human melanoma cell lines. Int J Oncol 2006; 29 (3): 665-72.
• Garcia-Santos G, Antolin I, Herrera F, et al. Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 2006; 41 (2): 130-5.

In vitro

• 1. Silver-Russell syndrome in a girl born after in vitro fertilization: partial hypermethylation at the differentially methylated region of PEG1/MEST. 
  Kagami M, Nagai T, Fukami M, Yamazawa K, Ogata T. J Assist Reprod Genet. 2007 Apr; 24(4):131-6.
• 2. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. 
  Buckett WM¹, Chian RC, Holzer H, Dean N, Usher R, Tan SL. Obstet Gynecol. 2007 Oct;110(4):885-91. 
• 3. Assisted reproductive technology may increase clinical mutation detection in male offspring.
  Feng C, Wang LQ, Dong MY, Huang HF. Fertil Steril. 2008 Jul;90(1):92-6. doi: 10.1016/j.fertnstert.2007.06.004.
• 4. Assisted reproductive technology and major structural birth defects in the United States.
  Reefhuis J¹, Honein MA, Schieve LA, Correa A, Hobbs CA, Rasmussen SA; National Birth Defects Prevention Study. Hum Reprod. 2009 Feb;24(2):360-6. doi: 10.1093/humrep/den387. Epub 2008 Nov 14. 
• 5. Managing the complications associated with assisted reproductive technologies.
  Patchava S¹, Gelbaya TA, Nardo LG.         Minerva Ginecol. 2009 Aug;61(4):347-55. 
• 6. Is it the patient or the IVF? Beckwith-Wiedemann syndrome in both spontaneous and assisted reproductive conceptions.  
  Strawn EY Jr¹, Bick D, Swanson A. Fertil Steril. 2010 Jul;94(2):754.e1-2. doi: 10.1016/j.fertnstert.2010.01.067. Epub 2010 Mar 24.  
• 7. [Retrospective studies of pregnancies after assisted medical reproduction from 2001-2009 and Central Hospital in Luxembourg (part 2)].  
  Arendt J, Schilling C, Peiffer M, Ginter S, Nahanb AF, Lemosb C, Duboisb M, Thononb F, Jouanb C, Gaspardb O, Larcher ME, Gomez V, Pereira S, Geimer M.    Bull Soc Sci Med Grand Duche Luxemb. 2010;(2):257-70. French.  
• 8. Child with Beckwith-Wiedemann syndrome born after assisted reproductive techniques to an human immunodeficiency virus serodiscordant couple.            
  Kuentz P¹, Bailly A, Faure AC, Blagosklonov O, Amiot C, Bresson JL, Roux C. Fertil Steril. 2011 Jul;96(1):e35-8. doi: 10.1016/j.fertnstert.2011.04.030. Epub 2011 May 7.  
• 9. Long-term follow-up of children conceived through assisted reproductive technology.
  Lu YH, Wang N, Jin F.                J Zhejiang Univ Sci B. 2013 May;14(5):359-71. doi: 10.1631/jzus.B1200348. Review.  
• 10. The impact of assisted reproductive technologies on genomic imprinting and imprinting disorders.
  Uyar A¹, Seli E.              Curr Opin Obstet Gynecol. 2014 Jun;26(3):210-21. doi: 10.1097/GCO.0000000000000071.  
• 11. A rare presentation of aplasia cutis congenita after feto-reduction in a trichorionic-triamniotic pregnancy.
  Vettori DJ¹, Jairath P².                 J Neonatal Perinatal Med. 2015;8(3):275-81. doi: 10.3233/NPM-15915003.  
• 12. Pregnancy-related complications and adverse pregnancy outcomes in multiple pregnancies resulting from assisted reproductive technology: a meta-analysis of cohort studies.
  Qin J, Wang H, Sheng X, Liang D, Tan H, Xia J. Fertil Steril. 2015 Jun;103(6):1492-508.e1-7. doi: 10.1016/j.fertnstert.2015.03.018. 
• 13. Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments.        
  Heisey AS¹, Bell EM, Herdt-Losavio ML, Druschel C. Birth Defects Res A Clin Mol Teratol. 2015 Feb;103(2):119-26. doi: 10.1002/bdra.23355. Epub 2015 Feb 12.  
• 14. Health and disease in children born after assistive reproductive therapies
  Hyrapetian M¹, Loucaides EM, Sutcliffe AG.              J Reprod Immunol. 2014 Dec;106:21-6.  
• 15. The impact of assisted reproductive technologies on intra-uterine growth and birth defects in singletons.
  Hansen M, Bower C.               Semin Fetal Neonatal Med. 2014 Aug;19(4):228-33. doi: 10.1016/j.siny.2014.03.002. Review.  
• 16. [Health and development of children conceived through assisted reproductive technologies].
  Epelboin S, Patrat C, Luton D.            Rev Prat. 2014 Jan;64(1):102-5. Review. French. 
• 17. [Interconnection between assisted reproductive technologies, pregnancy complications and risk of birth defects].
  Grabar' VV.           Georgian Med News. 2014 Feb;(227):7-14. Russian.  
• 18. Impact of ART on pregnancies in California: an analysis of maternity outcomes and insights into the added burden of neonatal intensive care.           
  Merritt TA¹, Goldstein M¹, Philips R¹, Peverini R¹, Iwakoshi J², Rodriguez A³, Oshiro B³. J Perinatol. 2014 May;34(5):345-50. doi: 10.1038/jp.2014.17. Epub 2014 Feb 20.  
• 19. Comparison of Congenital Abnormalities of Infants Conceived by Assisted Reproductive Techniques versus Infants with Natural Conception in Tehran.
  Farhangniya M, Dortaj Rabori E, Mozafari Kermani R, Haghdoost AA, Bahrampour A, Bagheri P, A L Lancaster P, Ashrafi M, Vosough Taqi Dizaj A, Gourabi H, Shahzadeh Fazeli A.                  Int J Fertil Steril. 2013 Oct;7(3):217-24.  
• 20. The impact of assisted reproductive technologies on the genome and epigenome of the newborn.
  Kochanski A¹, Merritt TA, Gadzinowski J, Jopek A.     J Neonatal Perinatal Med. 2013;6(2):101-8. doi: 10.3233/NPM-1366812.  
• 21. Silver-Russell syndrome due to paternal H19/IGF2 hypomethylation in a twin girl born after in vitro fertilization.
  Cocchi G¹, Marsico C, Cosentino A, Spadoni C, Rocca A, De Crescenzo A, Riccio A. Am J Med Genet A. 2013 Oct;161A(10):2652-5. doi: 10.1002/ajmg.a.36145. Epub 2013 Aug 16.  
• 22. Disparities in obstetrical outcomes in ART pregnancies compared with natural conceptions.   
  Plowden TC¹, Novak CM, Spong CY.          Semin Reprod Med. 2013 Sep;31(5):340-6. doi: 10.1055/s-0033-1348892. Epub 2013 Aug 9.  
• 23. Congenital malformations associated with assisted reproductive technology: a California statewide analysis.
  Kelley-Quon LI¹, Tseng CH, Janzen C, Shew SB.    J Pediatr Surg. 2013 Jun;48(6):1218-24. doi: 10.1016/j.jpedsurg.2013.03.017.  
• 24. [Follow-up of children conceived by assisted reproductive technologies].
  Bouillon C¹, Fauque P.            Arch Pediatr. 2013 May;20(5):575-9. doi: 10.1016/j.arcped.2013.02.003. Epub 2013 Mar 30.  
• 25. Analysis of birth defects among children 3 years after conception through assisted reproductive technology in China.
  Yin L¹, Hang F, Gu LJ, Xu B, Ma D, Zhu GJ. Birth Defects Res A Clin Mol Teratol. 2013 Nov;97(11):744-9. doi: 10.1002/bdra.23116. Epub 2013 Feb 25.  
• 26. Assisted reproductive technologies and perinatal morbidity: interrogating the association.
  Barnhart KT.             Fertil Steril. 2013 Feb;99(2):299-302. doi: 10.1016/j.fertnstert.2012.12.032.
• 27. Mothersisk update: reproductive outcomes after assisted conception.
  Neuman G¹, Koren G.         Can Fam Physician. 2013 Jan;59(1):33-4, 36.  
• 28. Congenital anomalies after assisted reproductive technology. 
  Pinborg A, Henningsen AK, Malchau SS, Loft A. Fertil Steril. 2013 Feb;99(2):327-32. doi: 10.1016/j.fertnstert.2012.12.001. Review.
• 29. The paediatric consequences of Assisted Reproductive Technologies, with special emphasis on multiple pregnancies.
  Barrington KJ, Janvier A. Acta Paediatr. 2013 Apr;102(4):340-8. doi: 10.1111/apa.12145. Review. 
• 30. The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluation.           
  Tararbit K, Lelong N, Thieulin AC, Houyel L, Bonnet D, Goffinet F, Khoshnood B; EPICARD Study Group.. Hum Reprod. 2013 Feb;28(2):367-74. doi: 10.1093/humrep/des400. 
• 31. [The prognosis for children born after assisted reproduction].
  Henningsen AK, Loft A, Malchau SS, Pinborg A. Ugeskr Laeger. 2012 Oct 8;174(41):2462-6. Danish.
• 32. Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies.    
  Hiura H, Okae H, Miyauchi N, Sato F, Sato A, Van De Pette M, John RM, Kagami M, Nakai K, Soejima H, Ogata T, Arima T. Hum Reprod. 2012 Aug;27(8):2541-8. doi: 10.1093/humrep/des197.  
• 33. Adverse perinatal events associated with ART.
  Skora D¹, Frankfurter D.        Semin Reprod Med. 2012 Apr;30(2):84-91. doi: 10.1055/s-0032-1307416. Epub 2012 Apr 27.  
• 34. Perinatal outcomes among children born by assisted reproductive techniques-a hospital-based case control study.
  Gupta P¹, Nayan N², Sharma M³. Med J Armed Forces India. 2012 Apr;68(2):132-5. doi: 10.1016/S0377-1237(12)60019-7. Epub 2012 Apr 21. 
• 35. Congenital anomalies in infants conceived by assisted reproductive techniques.
  Mozafari Kermani R¹, Nedaeifard L, Nateghi MR, Shahzadeh Fazeli A, Ahmadi E, Osia MA, Jafarzadehpour E, Nouri S. Arch Iran Med. 2012 Apr;15(4):228-31. doi: 012154/AIM.0011. 
• 36. Birth defects in singleton versus multiple ART births in Japan (2004-2008).
  Ooki S.    J Pregnancy. 2011;2011:285706. doi: 10.1155/2011/285706. 
• 37. Epigenetic imprinting during assisted reproductive technologies: The effect of temporal and cumulative fluctuations in methionine cycling on the DNA methylation state.
  Hoeijmakers L¹, Kempe H¹, Verschure PJ¹.    Mol Reprod Dev. 2016 Feb;83(2):94-107. doi: 10.1002/mrd.22605. Epub 2016 Jan 7. 
• 38. Influence of race and ethnicity on in vitro fertilization outcomes: systematic review.
  Humphries LA, Chang O, Humm K, Sakkas D, Hacker MR. Am J Obstet Gynecol. 2016 Feb;214(2):212.e1-212.e17. doi: 10.1016/j.ajog.2015.09.002. Review. 
• 39. [Occupational, educational and residential factors are associated with the outcomes of in vitro fertilization-embryo transfer].
  Hua R, Song Y, Wu B, Ni H, Yang X, Guo Y, Li H, Quan S, Yu Y. Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jan;36(1):44-9. Chinese.